Literature DB >> 653716

HLA polymorphism in Israel. 7. The Babylonian Jews.

E Gazit, C Brautbar, Y Mizrachi, R Cohen, H Yehoshua, R Zamir.   

Abstract

One hundred and twenty three Iraqi Jews, now living in Israel, were studied for their HLA polymorphism. Gene frequencies exceeding .1 were found for A1, A3, Aw19, B5, B12, and Bw35. A28, B8 and B14 were relatively rare whereas Aw25 and Bw37 were not found at all. Significant gametic associations occurred for (Aw23, Bw21), (Aw26, Bw16), (A11, B5), (A28, B8) and (A28, B7). The Iraqi Jewish population was found to be typical of Asiatics and Middle Easterners.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 653716     DOI: 10.1111/j.1399-0039.1978.tb01253.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  5 in total

1.  The relationship between HLA antigens and Bermuda grass hayfever.

Authors:  C Geller-Bernstein; R Kenett; R Zamir; S Karlin; M Sela
Journal:  Immunogenetics       Date:  1978-12       Impact factor: 2.846

2.  Close association of HLA-B51 and B52 in Israeli patients with Behçet's syndrome.

Authors:  N Arber; T Klein; Z Meiner; E Pras; A Weinberger
Journal:  Ann Rheum Dis       Date:  1991-06       Impact factor: 19.103

Review 3.  Analysis of genetic data on Jewish populations. I. Historical background, demographic features, and genetic markers.

Authors:  B Bonné-Tamir; S Karlin; R Kenett
Journal:  Am J Hum Genet       Date:  1979-05       Impact factor: 11.025

4.  Age-dependent HLA profiles of the Israeli population: impact on hematopoietic cell donor recruitment and availability.

Authors:  Moshe Israeli; Machteld Oudshoorn; Geert W Haasnoot; Tirza Klein; Bracha Zisser; Gideon Bach; Frans H J Claas
Journal:  Immunogenetics       Date:  2014-10       Impact factor: 2.846

5.  The polyglandular deficiency syndrome: a new variant in Persian Jews.

Authors:  M S Shapiro; R Zamir; E Weiss; J Radnay; L Shenkman
Journal:  J Endocrinol Invest       Date:  1987-02       Impact factor: 4.256

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.